Target Price | $7.58 |
Price | $6.29 |
Potential |
20.56%
register free of charge
|
Number of Estimates | 6 |
6 Analysts have issued a price target Adaptive Biotechnologies Corp 2025 .
The average Adaptive Biotechnologies Corp target price is $7.58.
This is
20.56%
register free of charge
$10.00
58.98%
register free of charge
$5.50
12.56%
register free of charge
|
|
A rating was issued by 8 analysts: 6 Analysts recommend Adaptive Biotechnologies Corp to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Adaptive Biotechnologies Corp stock has an average upside potential 2025 of
20.56%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 170.28 | 177.71 |
8.11% | 4.36% | |
EBITDA Margin | -105.34% | -52.81% |
14.82% | 49.87% | |
Net Margin | -135.19% | -93.00% |
21.26% | 31.21% |
8 Analysts have issued a sales forecast Adaptive Biotechnologies Corp 2024 . The average Adaptive Biotechnologies Corp sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Adaptive Biotechnologies Corp EBITDA forecast 2024. The average Adaptive Biotechnologies Corp EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Adaptive Biotechnologies Corp Analysts have issued a net profit forecast 2024. The average Adaptive Biotechnologies Corp net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.56 | -1.12 |
11.43% | 28.21% | |
P/E | negative | |
EV/Sales | 5.12 |
3 Analysts have issued a Adaptive Biotechnologies Corp forecast for earnings per share. The average Adaptive Biotechnologies Corp <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Adaptive Biotechnologies Corp stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Adaptive Biotechnologies Corp...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.